Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wissing

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Transplantation|February 24, 2001
Fatal primary infection due to human herpesvirus 6 variant A in a renal transplant recipientC Rossi, M L Delforge, F Jacobs, et al.
Transplantation|May 27, 1994
Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10V Donckier, V Flament, C Gérard, et al.
Toxicology and Applied Pharmacology|May 28, 2013
Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosisKatrien Van Beneden, Caroline Geers, Marina Pauwels, et al.
Transplantation|March 7, 2008
HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodiesKarl M Wissing, Guy Fomegné, Nilufer Broeders, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2011
The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipientsS M Flechner, M Glyda, S Cockfield, et al.
Clinical Kidney Journal|March 18, 2016
Therapeutic drug monitoring of enteric-coated mycophenolate sodium by limited sampling strategies is associated with a high rate of failureJean-Michel Hougardy, Laurette Maufort, Frédéric Cotton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 17, 2018
Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantationKarl M Wissing, Daniel Abramowicz, Laurent Weekers, et al.
Acta Obstetricia Et Gynecologica Scandinavica|July 1, 2015
Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypesMubeena Aziz, Johannes J Sidelmann, Jens Faber, et al.
Clinical Transplantation|August 20, 2010
Ineligibility for renal transplantation: prevalence, causes and survival in a consecutive cohort of 445 patientsMireille N Kianda, Karl M Wissing, Nulifer E Broeders, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 2, 2011
Recurrent leishmaniasis in kidney transplant recipients: report of 2 cases and systematic review of the literatureI Simon, K M Wissing, V Del Marmol, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Transplantation|February 24, 2001
Fatal primary infection due to human herpesvirus 6 variant A in a renal transplant recipientC Rossi, M L Delforge, F Jacobs, et al.
Transplantation|May 27, 1994
Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10V Donckier, V Flament, C Gérard, et al.
Toxicology and Applied Pharmacology|May 28, 2013
Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosisKatrien Van Beneden, Caroline Geers, Marina Pauwels, et al.
Transplantation|March 7, 2008
HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodiesKarl M Wissing, Guy Fomegné, Nilufer Broeders, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2011
The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipientsS M Flechner, M Glyda, S Cockfield, et al.
Clinical Kidney Journal|March 18, 2016
Therapeutic drug monitoring of enteric-coated mycophenolate sodium by limited sampling strategies is associated with a high rate of failureJean-Michel Hougardy, Laurette Maufort, Frédéric Cotton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 17, 2018
Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantationKarl M Wissing, Daniel Abramowicz, Laurent Weekers, et al.
Acta Obstetricia Et Gynecologica Scandinavica|July 1, 2015
Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypesMubeena Aziz, Johannes J Sidelmann, Jens Faber, et al.
Clinical Transplantation|August 20, 2010
Ineligibility for renal transplantation: prevalence, causes and survival in a consecutive cohort of 445 patientsMireille N Kianda, Karl M Wissing, Nulifer E Broeders, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 2, 2011
Recurrent leishmaniasis in kidney transplant recipients: report of 2 cases and systematic review of the literatureI Simon, K M Wissing, V Del Marmol, et al.
Pageof 7